中国组织工程研究与临床康复
中國組織工程研究與臨床康複
중국조직공정연구여림상강복
JOURNAL OF CLINICAL REHABILITATIVE TISSUE ENGINEERING RESEARCH
2010年
8期
1475-1478
,共4页
有晶状体眼%人工晶状体%高度近视%后房%生物材料
有晶狀體眼%人工晶狀體%高度近視%後房%生物材料
유정상체안%인공정상체%고도근시%후방%생물재료
背景:有晶体眼人工晶体植入术具有潜在的可逆性和保留了调节力等优点,是目前富有潜力的屈光手术.而后房型有晶体眼人工晶体植入术是近几年发展起来的矫正高度近视的方法,有其独特的优越性.目的:探讨有晶体眼后房型人工晶体植入术矫正高度近视的稳定性、有效性和安全性.方法:选择2006-03/2009-01在山东施尔明眼科医院行后房型有晶体眼人工晶体植入矫正高度近视患者11例(18眼),男4例(7眼),女7例(11眼).术后随访3~6个月(平均5.3个月),观察屈光度、眼压、对比敏感度、眩光敏感度、角膜内皮计数及晶体的混浊情况等.结果与结论:术后6个月裸眼视力均≥术前矫正视力,术后散光明显减轻,裸眼对比敏感度及眩光敏感度值在全频明显提高,术后6个月前房深度、角膜内皮细胞数及眼压与术前比较无明显变化;随访6个月未出现严重并发症;2例患者出现夜间视力降低及眩光的现象.说明短期内观察有晶体眼后房型人工晶体植入矫正高度近视具有良好的可预测性、安全性和稳定性,是一种颇具前途的高度近视矫治方法.
揹景:有晶體眼人工晶體植入術具有潛在的可逆性和保留瞭調節力等優點,是目前富有潛力的屈光手術.而後房型有晶體眼人工晶體植入術是近幾年髮展起來的矯正高度近視的方法,有其獨特的優越性.目的:探討有晶體眼後房型人工晶體植入術矯正高度近視的穩定性、有效性和安全性.方法:選擇2006-03/2009-01在山東施爾明眼科醫院行後房型有晶體眼人工晶體植入矯正高度近視患者11例(18眼),男4例(7眼),女7例(11眼).術後隨訪3~6箇月(平均5.3箇月),觀察屈光度、眼壓、對比敏感度、眩光敏感度、角膜內皮計數及晶體的混濁情況等.結果與結論:術後6箇月裸眼視力均≥術前矯正視力,術後散光明顯減輕,裸眼對比敏感度及眩光敏感度值在全頻明顯提高,術後6箇月前房深度、角膜內皮細胞數及眼壓與術前比較無明顯變化;隨訪6箇月未齣現嚴重併髮癥;2例患者齣現夜間視力降低及眩光的現象.說明短期內觀察有晶體眼後房型人工晶體植入矯正高度近視具有良好的可預測性、安全性和穩定性,是一種頗具前途的高度近視矯治方法.
배경:유정체안인공정체식입술구유잠재적가역성화보류료조절력등우점,시목전부유잠력적굴광수술.이후방형유정체안인공정체식입술시근궤년발전기래적교정고도근시적방법,유기독특적우월성.목적:탐토유정체안후방형인공정체식입술교정고도근시적은정성、유효성화안전성.방법:선택2006-03/2009-01재산동시이명안과의원행후방형유정체안인공정체식입교정고도근시환자11례(18안),남4례(7안),녀7례(11안).술후수방3~6개월(평균5.3개월),관찰굴광도、안압、대비민감도、현광민감도、각막내피계수급정체적혼탁정황등.결과여결론:술후6개월라안시력균≥술전교정시력,술후산광명현감경,라안대비민감도급현광민감도치재전빈명현제고,술후6개월전방심도、각막내피세포수급안압여술전비교무명현변화;수방6개월미출현엄중병발증;2례환자출현야간시력강저급현광적현상.설명단기내관찰유정체안후방형인공정체식입교정고도근시구유량호적가예측성、안전성화은정성,시일충파구전도적고도근시교치방법.
BACKGROUND: The phakic intraocular lens implantation has advantages of reversibility and accommodative capability, which is a promising refractive operation. Posterior chamber phakic intraocular lens implantation is a developing method for the correction of extreme myopia. OBJECTIVE: To evaluate the efficacy, safety and stability of posterior chamber phakic intraocular lens implantation for the correction of extreme myopia. METHODS: This study included 18 eyes of 11 patients whose received posterior chamber phakic intraocular lens implantation at Shierming Eye Hospital from March 2006 to January 2009, including 4 males (7 eyes) and 7 females (11 eyes). All patients were followed-up 3-6 months, mean 5.3 months. The refraction, intraocular pressure, contrast sensitivity, glare sensitivity, endothelial cell morphometry, as well as lens opacities were observed. RESULTS AND CONCLUSION: After operation, naked visions of the 18 eyes were better than or equal to preoperative corrective vision, and the astigmatism was relieved obviously. The naked contrast sensitivity and glare sensitivity was better than that before the operation. The anterior chamber depth, intraocular pressure and corneal endothelium counting before and after the operation had no significant difference. No serious complication was detected during the follow-up. The vision decent at night and dazzling sensation occurred in 2 cases. Shot-term observation shows that implanting intraocular lens in posterior chamber to correct high myopia is safe, stable and predictable. This operation is a promising method for correcting high myopia.